Literature DB >> 28108544

The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer.

Valeria Governa1,2, Emanuele Trella1, Valentina Mele1, Luigi Tornillo2, Francesca Amicarella1, Eleonora Cremonesi1, Manuele Giuseppe Muraro1, Hui Xu1, Raoul Droeser1,3, Silvio R Däster1,3, Martin Bolli4, Raffaele Rosso5, Daniel Oertli3, Serenella Eppenberger-Castori2, Luigi M Terracciano2, Giandomenica Iezzi1, Giulio C Spagnoli6.   

Abstract

Purpose: Tumor infiltration by different T lymphocyte subsets is known to be associated with favorable prognosis in colorectal cancer. Still debated is the role of innate immune system. We investigated clinical relevance, phenotypes, and functional features of colorectal cancer-infiltrating CD66b+ neutrophils and their crosstalk with CD8+ T cells.Experimental Design: CD66b+ and CD8+ cell infiltration was analyzed by IHC on a tissue microarray including >650 evaluable colorectal cancer samples. Phenotypic profiles of tissue-infiltrating and peripheral blood CD66b+ cells were evaluated by flow cytometry. CD66b+/CD8+ cells crosstalk was investigated by in vitro experiments.
Results: CD66b+ cell infiltration in colorectal cancer is significantly associated with increased survival. Interestingly, neutrophils frequently colocalize with CD8+ T cells in colorectal cancer. Functional studies indicate that although neutrophils are devoid of direct antitumor potential, coculture with peripheral blood or tumor-associated neutrophils (TAN) enhances CD8+ T-cell activation, proliferation, and cytokine release induced by suboptimal concentrations of anti-CD3 mAb. Moreover, under optimal activation conditions, CD8+ cell stimulation in the presence of CD66b+ cells results in increasing numbers of cells expressing CD45RO/CD62L "central memory" phenotype. Importantly, combined tumor infiltration by CD66b+ and CD8+ T lymphocytes is associated with significantly better prognosis, as compared with CD8+ T-cell infiltration alone.Conclusions: Neutrophils enhance the responsiveness of CD8+ T cells to T-cell receptor triggering. Accordingly, infiltration by neutrophils enhances the prognostic significance of colorectal cancer infiltration by CD8+ T cells, suggesting that they might effectively promote antitumor immunity. Clin Cancer Res; 23(14); 3847-58. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28108544     DOI: 10.1158/1078-0432.CCR-16-2047

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  68 in total

Review 1.  Recent advances on the crosstalk between neutrophils and B or T lymphocytes.

Authors:  Sara Costa; Dalila Bevilacqua; Marco A Cassatella; Patrizia Scapini
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

Review 2.  Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy.

Authors:  Sandra Meršaková; Zora Lasabová; Ján Strnádel; Michal Kalman; Eva Gabonova; Peter Sabaka; Rachele Ciccocioppo; Luis Rodrigo; Peter Kruzliak; Peter Mikolajčík
Journal:  Clin Exp Med       Date:  2020-07-27       Impact factor: 3.984

Review 3.  Neutrophil Diversity in Health and Disease.

Authors:  Carlos Silvestre-Roig; Zvi G Fridlender; Michael Glogauer; Patrizia Scapini
Journal:  Trends Immunol       Date:  2019-05-31       Impact factor: 16.687

Review 4.  Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.

Authors:  Debashree Basudhar; Gaurav Bharadwaj; Veena Somasundaram; Robert Y S Cheng; Lisa A Ridnour; Mayumi Fujita; Stephen J Lockett; Stephen K Anderson; Daniel W McVicar; David A Wink
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

5.  Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.

Authors:  Juha P Väyrynen; Mai Chan Lau; Koichiro Haruki; Sara A Väyrynen; Jeffrey A Meyerhardt; Marios Giannakis; Shuji Ogino; Jonathan A Nowak; Andressa Dias Costa; Jennifer Borowsky; Melissa Zhao; Kenji Fujiyoshi; Kota Arima; Tyler S Twombly; Junko Kishikawa; Simeng Gu; Saina Aminmozaffari; Shanshan Shi; Yoshifumi Baba; Naohiko Akimoto; Tomotaka Ugai; Annacarolina Da Silva; Mingyang Song; Kana Wu; Andrew T Chan; Reiko Nishihara; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2020-05-21       Impact factor: 12.531

6.  Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.

Authors:  B Weixler; F Renetseder; I Facile; N Tosti; E Cremonesi; A Tampakis; T Delko; S Eppenberger-Castori; A Tzankov; G Iezzi; C Kettelhack; S D Soysal; U von Holzen; G C Spagnoli; L Terracciano; L Tornillo; Raoul A Droeser; S Däster
Journal:  Cell Oncol (Dordr)       Date:  2017-09-21       Impact factor: 6.730

7.  Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis.

Authors:  Tyler J Goodwin; Leaf Huang
Journal:  Vaccine       Date:  2017-04-03       Impact factor: 3.641

Review 8.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

Review 9.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

10.  Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.

Authors:  Sumana Narayanan; Tsutomu Kawaguchi; Li Yan; Xuan Peng; Qianya Qi; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2018-05-16       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.